Based on his remarks at this morning’s CC, Retrophin CEO Martin Shkreli disagrees with Birchenoff. Shkreli seemed pretty confident Chenodal would work as well as Intercept’s drug for PBC & NASH. I wonder who to believe. ;~) Peace & good health, Bulba
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.